Skip to Primary Navigation

Skip to main content

Medicare to offer $50 monthly access to GLP‑1 drugs under new CMS demonstration

A photo of Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz smiling.
Centers for Medicare and Medicaid Services Administrator Dr Mehmet Oz. Photo: Brandon Bell/Getty Images

Kevin Kinsella

3 min read

Part D enrollees will gain $50 monthly access to select GLP-1 medications through a new CMS demonstration program – but at what price?

The Centers for Medicare & Medicaid Services (CMS) have announced a new program for seniors to access certain GLP-1 medications monthly at a sharply reduced cost.

The limited-time Medicare GLP-1 Bridge program will provide eligible Medicare beneficiaries access to certain GLP-1 medications for $50 per month beginning July 1, 2026,

, , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial
Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience